Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison. 2004

Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
Army Health Branch, Israel Defense Force Medical Corps, Military Post 02149, Israel. mhuerta@netvision.net.il

BACKGROUND In March 2000, the Israel Defense Force (IDF) experienced an outbreak of rubella. No population-based rubella seroepidemiologic data were available for the 13-year period preceding the epidemic. METHODS We conducted a population-based seroprevalence study of rubella antibodies among 289 IDF recruits drafted in 1999. RESULTS We found that 69.2% of males and 90.8% of females in service were seropositive at recruitment in 1999, immediately before the outbreak. These rates were significantly lower than those last measured in 1987 (88% among males and 98.1% among females). CONCLUSIONS Our findings indicate that this rubella outbreak among young adults was facilitated by a decrease in immunity to levels below those required for herd immunity, at which epidemic virus transmission was no longer blocked. This is most likely due to widespread pediatric vaccination coverage with incomplete catch-up immunization among adolescents and young adults. These findings serve as a reminder that changes to childhood vaccination programs may affect the epidemiology of disease among older segments of the population several years after the change is implemented.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological

Related Publications

Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
October 1992, Israel journal of medical sciences,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
June 2003, The Southeast Asian journal of tropical medicine and public health,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
January 2013, Intervirology,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
January 2017, The Southeast Asian journal of tropical medicine and public health,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
September 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
September 2013, Human vaccines & immunotherapeutics,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
March 1983, Lancet (London, England),
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
January 1994, Canadian journal of public health = Revue canadienne de sante publique,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
January 2006, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi,
Michael Huerta, and Nadav Davidovitch, and Omer E Ankol, and Yona Zaaide, and Itamar Grotto, and Ran D Balicer, and Eli Zangvil
December 2014, Central European journal of public health,
Copied contents to your clipboard!